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Objectives This study sought to determine the accuracy of 3-dimensional, quantitative measure-
ments of coronary plaque by computed tomography angiography (CTA) against intravascular ultra-
sound with radiofrequency backscatter analysis (IVUS/VH).
Background Quantitative, 3-dimensional coronary CTA plaque measurements have not been vali-
dated against IVUS/VH.
Methods Sixty patients in a prospective study underwent coronary X-ray angiography, IVUS/VH, and
coronary CTA. Plaque geometry and composition was quantiﬁed after spatial coregistration on segmental
and slice-by-slice bases. Correlation, mean difference, and limits of agreement were determined.
Results There was signiﬁcant correlation for all pre-speciﬁed parameters by segmental and slice-by-
slice analyses (r  0.41 to 0.84; all p  0.001). On a segmental basis, CTA underestimated minimal
lumen diameter by 21% and overestimated diameter stenosis by 39%. Minimal lumen area was
overestimated on CTA by 27% but area stenosis was only underestimated by 5%. Mean difference in
noncalciﬁed plaque volume and percent and calciﬁed plaque volume and percent were 38%, 22%,
104%, and 64%. On a slice-by-slice basis, lumen, vessel, noncalciﬁed-, and calciﬁed-plaque areas
were overestimated on CTA by 22%, 19%, 44%, and 88%. There was signiﬁcant correlation for per-
centage of atheroma volume (0.52 vs. 0.54; r  0.51; p  0.001). Compositional analysis suggested
that high-density noncalciﬁed plaque on CTA best correlated with ﬁbrous tissue and low-density
noncalciﬁed plaque correlated with necrotic core plus ﬁbrofatty tissue by IVUS/VH.
Conclusions This is the ﬁrst validation that standardized, 3-dimensional, quantitative measurements of
coronary plaque correlate with IVUS/VH. Mean differences are small, whereas limits of agreement are
wide. Low-density noncalciﬁed plaque correlates with necrotic core plus ﬁbrofatty tissue on IVUS/VH. (J Am
Coll Cardiol Intv 2011;4:198–208) © 2011 by the American College of Cardiology Foundation
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199Atherogenic lipoprotein particle deposition and the ensuing
inflammation in the arterial wall result in geometric and
compositional changes that can be detected by imaging mo-
dalities (1). Traditionally, intravascular ultrasound (IVUS) has
been used for precise measurements of plaque geometric
parameters (2,3) and several tissue characterization approaches
have also been introduced based on IVUS, such as radiofre-
quency backscatter (intravascular ultrasound with radio fre-
quency backscatter analysis [IVUS/VH]) (4), elastography, and
palpography (5). Both grayscale IVUS-based geometric mea-
surements and IVUS/VH-based compositional measurements
have been shown to predict clinical outcomes (6,7).
See page 209
Contrast-enhanced coronary computed tomography an-
giography (CTA) has been introduced for stenosis detection
(8) and CTA has also been proposed as an emerging tool for
he detection, characterization, and quantification of coronary
therosclerotic plaques (9–12). Although a few studies have
valuated the accuracy of CTA for the measurement of
eometric and compositional plaque parameters, precise quan-
itative plaque measurements by CTA have not been validated
gainst IVUS/VH. We recently developed a standardized,
eproducible, 3-dimensional, quantitative method for the
uantification of geometric and compositional coronary plaque
arameters (12).Whether quantitative CTA-derived measure-
ents are precise enough on a per-patient level and on a
opulation level is important, as such precision will determine
hether CTA-derived quantitative measurements can be used
n clinical practice in individual patients and in populations, for
linical research purposes.
The primary objective of the present study was to evaluate
he accuracy of these standardized, 3-dimensional measure-
ents on a segmental basis, using IVUS/VH as reference
tandard. The secondary objective was to determine the accu-
acy of CTA measurements on a slice-by-slice basis against
VUS/VH. The tertiary objective was to determine plaque
omponents by IVUS/VH that correspond to high-density
nd low-density noncalcified plaque (HD-NCP and LD-
CP) on CTA. We hypothesized that CTA-derived mea-
urements significantly correlate with IVUS/VH measure-
ents.
ethods
General study design. The ATLANTA (Assessment of Tis-
ue Characteristics, Lesion Morphology, and Hemodynamics
y Angiography With Fractional Flow Reserve, Intravascular
ltrasound and Virtual Histology, and Noninvasive Com-
uted Tomography in Atherosclerotic Plaques) study was a
rospective, single-center, investigator-initiated study ap-
roved by the Institutional Review Board of PiedmontHealth-
are. The general study design is shown in Figure 1. Here weeport the results of phase I, which included a multimodality
pproach to intermediate coronary lesions in patients without
revious coronary artery disease who presented with signs or
ymptoms suggestive of myocardial ischemia. Patients with
ntermediate coronary arterial lesions were included from either
he cardiac catheterization laboratory or the CT laboratory. All
atients underwent invasive X-ray coronary angiography
XRA) with quantitative coronary angiography (QCA), frac-
ional flow reserve measurements, IVUS/VH, and multislice
TA. We evaluated and cross-validated luminal stenosis,
laque geometry, plaque compo-
ition, and hemodynamic mea-
urements among all involved
odalities.
Invasive X-ray coronary angiog-
raphy. Invasive X-ray coronary
angiography was performed by
the Judkins technique based on
standard institutional protocols,
with a minimum of 5 views of
the left and 2 views of the right
coronary systems. Once the
study lesion was identified, we
performed at least 2 orthogonal
views for QCA purposes.
CT coronary angiography image
acquisition. All image acquisition
was performed on a 32  2 CT
system (Somatom 64, Siemens, Er-
langen, Germany) using our insti-
tutional imaging protocols as pub-
lished (13). Contrast-enhanced
coronary artery CTA was per-
formed during end-expiratory
breath-hold using retrospective
electrocardiographic-gating. Oral
and intravenous metoprolol was ad-
ministered as needed to keep the
heart rate below60 beats/min.After
noncontrast localization image ac-
quisition, a test bolus of 20 ml io-
dinated contrast (Visipaque, GE
Amersham Health, Sunnyvale,
California) was administered at a
rate of 3 to 5 ml/s to determine the delay until the arrival of the
contrast in the ascending aorta for optimal opacification of the
coronary arteries. Coronary arterial image acquisition was
performed using 60 to 80 ml of intravenous contrast followed
by 30 ml of normal saline flush. Acquisition parameters
included 32  2 detector rows, 0.6-mm collimation, gantry
rotation 330 ms, pitch 0.24, tube voltage 120 kV, and tube
current 800 to 950 mA. Images were reconstructed in 0.6-mm
axial slices using 3 different reconstruction algorithms in 10
Abbreviations
and Acronyms
%AS  percentage of
area stenosis
%DS  percentage of
diameter stenosis
CAP  calcified
atherosclerotic plaque
CTA  computed
tomography angiography
FF  fibrofatty
FI  fibrous
HD-NCP  high-density
noncalcified plaque
IVUS  intravascular
ultrasound
IVUS/VH  intravascular
ultrasound with
radiofrequency backscatter
analysis
LD-NCP  low-density
noncalcified plaque
MLA  minimal lumen area
MLD  minimal lumen
diameter
NC  necrotic core
NCP  noncalcified plaque
PAV  percentage of
atheroma volume
QCA  quantitative coronary
angiography
XRA  invasive X-ray
coronary angiographyphases of the cardiac cycle.
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200IVUS/VH image acquisition. After intracoronary injection of
nitroglycerin (mean total dose per case: 561.5 g; range 0 to
,800 g) and after placing a guiding catheter in the target
oronary artery, a 3.2-F, 20-mHz ultrasound catheter (Ea-
le Eye, Volcano Inc., Rancho Cordova, California) was
nserted and was advanced at least 2 cm beyond the most
istal portion of the target lesion. Automated pullback was
erformed at a rate of 0.5 mm/s (R-100, Volcano Inc.). The
lectrocardiographic signal was simultaneously recorded for
he reconstruction of the radiofrequency backscatter infor-
ation using In-Vision gold (Volcano Inc.).
Figure 1. Overall Study Design
The overall study design is shown as a ﬂow chart. Patients underwent quantit
intravascular ultrasound with radiofrequency backscatter analysis (IVUS/VH) at
X-ray coronary angiography.
Figure 2. Anatomical Coregistration Between XRA, CTA, and IVUS/VH
Anatomical, segmental coregistration of XRA, CTA, IVUS, and IVUS/VH datasets
a longitudinal view (B) and in cross section is shown at the area of the minim
(D, E) and IVUS/VH datasets (F, G) are shown in long-axis view (D, F) and in cross-sAnatomical image coregistration and image analysis. One
pre-specified study lesion was identified in each patient. An
anatomical segment containing the entirety of the study
lesion was then selected, which could be easily identified
based on standard anatomical landmarks on all 3 modalities
(XRA, CTA, and IVUS/VH) using septal, diagonal, obtuse
marginal, and right ventricular marginal branches (Fig. 2).
Once the study segment was identified, it was indepen-
dently analyzed on all 3 modalities.
QCA. Deidentified angiographic datasets were transferred
to a free-standing workstation (Encompass, version 2.0, B17,
oronary angiography (QCA), computed tomography angiography (CTA), and
ne and CTA 12 months later. FFR  fractional ﬂow reserve; XRA  invasive
ll-deﬁned segment on XRA is shown (A). Corresponding segment on CTA in
en area (MLA) (C). Corresponding grayscale intravascular ultrasound (IVUS)ative c
baseli. A we
al lumectional view (E, G) at the area of MLA. Abbreviations as in Figure 1.
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201HeartLab, Westerly, Rhode Island) and were presented to an
interventional cardiologist (A.K.) with 16 years of experience
in random order. The study lesion and study segment were
identified in multiple projections and lesion borders were
contoured manually. Minimal lumen diameter and reference
diameter were measured and percentage of diameter stenosis
(%DS) was calculated.
CTA IMAGE ANALYSIS. Deidentified datasets were transferred
to a dedicated workstation (Vitrea 2.0, Vital Images, Minne-
tonka, Minnesota) and were analyzed by an experienced, level
III trained cardiologist (S.R.), using our previously described,
standardized, and reproducible 3-dimensional approach (9,12).
Starting and terminating points of each study segment con-
taining the study lesion were carefully selected to match the
corresponding landmarks on XRA and IVUS/VH (Fig. 2).
Within each segment, we determined geometric and compo-
sitional parameters. Geometric parameters included minimal
lumen diameter (MLD), %DS, minimal lumen area (MLA),
and percentage of area stenosis (%AS). Percentage of atheroma
volume (PAV) was calculated using the following equation:
(total vessel area – total lumen area)/total vessel area. Compo-
sitional parameters included the volume and percentage of 3
components: calcified atherosclerotic plaque, HD-NCP, and
LD-NCP. Between the outer vessel wall boundary and the
luminal boundary, voxels were classified as CAP with attenu-
Figure 3. Slice-by-Slice Coregistration Between CTA and IVUS/VH
Example of precisely coregistered IVUS (A, C) and CTA (B, D) datasets on a sli
coronary artery by CTA (green) and IVUS (red) before spatial coregistration (E
patient; other abbreviations as in Figures 1 and 2.ation values 150 HU (Hounsfield units) or greater, as HD-
NCP with 30 to 149 HU and as LD-NCP with100 to30
HU. Total volume and percentage of each of the 3 components
were measured in each study segment. Volume and percentage
of NCP was calculated as the sum of HD-NCP and LD-
NCP. We have previously evaluated and published inter-rater
reliability for this approach (9,12,14,15).
IVUS/VH IMAGE ANALYSIS. Deidentified IVUS/VH datasets
ere transferred to a dedicated workstation and were
nalyzed using dedicated software (pcVH, version 3.0.394,
olcano Inc.) by an experienced cardiologist (G.V.). The
uminal boundary and the external elastic lamina were
ontoured in a semiautomatic fashion in each frame. Based
n a previously validated algorithm, the software classified
ach pixel as dense calcium (white color), fibrous (FI) tissue
green color), fibrofatty (FF) tissue (light green color), and
ecrotic core (NC) (red color) (Figs. 2F and 2G). Total
olume and percentage of each of the 4 components was
easured in the study segment. Furthermore, we calculated
he volume and percentage of all NCP components (sum of
C, FF, and FI).
Slice-by-slice image coregistration and analysis. We per-
formed a precise, slice-by-slice coregistration in a subset of
patients with the best image quality based on the shape of
the lumen on the respective modalities. After careful and
slice basis. Slice-by-slice variation of MLA is tracked from the ostium of the
after precise slice-by-slice spatial coregistration (F). ATL  ATLANTA studyce-by-
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202precise alignment of the starting and termination points of
each segment on CTA and IVUS/VH, we identified com-
pletely matching slices between the 2 modalities and deter-
mined lumen area, vessel area, CAP area, and NCP area in
each corresponding image pair (Fig. 3).
Statistical methods. Normally distributed continuous vari-
bles were expressed as mean  SD and were compared by
-tailed, unpaired t test, and non-normally distributed contin-
ous variables were expressed as median (interquartile range)
nd were compared using the Mann-Whitney U test. Corre-
ation was assessed by linear correlation; mean differences and
imits of agreement were assessed by Bland-Altman analysis. A
value of 0.05 or less was considered statistically significant.
PRIMARY END POINT. The pre-specified primary end point
f the study was the correlation between CTA and
VUS/VH for PAV measurements.
esults
Patient characteristics. Of the 60 patients enrolled, 50 had
corresponding, interpretable, simultaneous CTA and
IVUS/VH datasets, excluding 10 patients from the analysis.
In 5 of these 10 patients, the IVUS catheter could not be
passed and in another 5 patients, the IVUS/VH image
quality was not sufficient for quantitative analysis. Of the 10
patients that were excluded, 1 also had poor CT image
quality. Demographic characteristics are shown in Table 1.
In general, our population was typical for a population with
no previous coronary artery disease who presented with
new-onset symptoms, with a mean age of 58.7  6.9 years.
Study lesion data. Of the 50 study lesions in 50 patients, 39
78%) were in the left anterior descending, 5 (10%) in the
eft circumflex, and 6 (12%) in the right coronary artery;
ean length of the analyzed segments was 26.8 12.5 mm.
Correlation between QCA and CTA. Although mean differ-
nces for MLD and %DS were small between QCA and
TA, limits of agreement were wide (72% and 85% of the
easurement, respectively) (Fig. 4) (Table 2).
Correlation between CTA and IVUS/VH based on anatomical
coregistration. Scatterplots with regression lines and Bland-
Altman plots for CTA and IVUS/VH parameters are
shown in Figure 5 for geometric and in Figure 6 for plaque
compositional parameters. Mean values, correlation coeffi-
cients, mean differences, and limits of agreement are shown in
Table 3. Overall, there was statistically significant correlation
for all parameters. Correlation was strongest for NCP volume
(r 0.84), CAP volume (r 0.65), and MLA (r 0.65) and
was weakest for percentage of NCP (NCP-%) (r  0.41) and
for percentage of CAP (CAP-%) (r  0.41).
Correlation between CTA and IVUS/VH based on slice-by-slice
coregistration. We performed precise, slice-by-slice coregis-
tration in 731 slices in 14 patients with the best image quality.
Scatterplots with regression lines and Bland-Altman plots for
lumen area, vessel area, and PAV are shown in Figure 7,revealing significant correlation for all 3 parameters on a
slice-by-slice basis. Examples of simultaneous lumen and vessel
wall measurements by CTA and IVUS/VH are shown in
Figure 3, confirming that CTA-based measurements can
accurately track the true slice-by-slice variation in lumen and
vessel area as measured by IVUS/VH. Furthermore, there was
significant correlation between CTA and IVUS/VH measure-
ments of PAV (0.52  0.13 and 0.54  0.13 by CTA and
IVUS, respectively; r  0.51; p  0.001). Mean values,
correlation coefficients, mean differences, and limits of agree-
ment are shown in Table 4. Scatterplots with regression lines
and Bland-Altman plots for CAP area and NCP area are
shown in Figure 8, revealing significant correlation for both
parameters on a slice-by-slice basis. Overall, correlation was
strongest for lumen area (r  0.77) and vessel area (r  0.72)
and was weakest for NCP area (r  0.46) and for CAP area
(r  0.43).
To explore plaque components on IVUS/VH that corre-
Table 1. General Demographic Characteristics of Study Patients
Age, yrs 58.7 6.9
Men, % 58%
Ethnicity
Caucasian 90%
African American 10%
Risk factors
Hypertension 80%
Dyslipidemia 94%
Tobacco use (former or current) 80%
Diabetes 26%
Framingham risk score (10-yr risk) 8.2 6.1
Symptoms
Chest pain (angina) 50%
Shortness of breath 28%
Medications
Aspirin 66%
Beta blocker 52%
ACE inhibitor 28%
ARB 12%
Nitrate 8%
Statin 68%
Cholesterol absorption inhibitor 28%
Niacin 16%
Fibric acid derivative 6%
Laboratory values
Total cholesterol, mg/dl 166 46.7
ApoB, mg/dl 86.9 29.2
LDL-cholesterol, mg/dl 94.2 38.4
ApoAI, mg/dl 139.6 31.4
HDL-cholesterol, mg/dl 38.9 13.2
Values are expressed as mean SD or %.
ACE angiotensin-converting enzyme; ApoAI apolipoprotein AI; apoB apolipoprotein B;
ARB angiotensin receptor blocker; HDLhigh-density lipoprotein; LDL low-density lipopro-
tein.spond to HD-NCP and LD-NCP on CTA, we compared
Dbrevi
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203correlation coefficients between CTA- and IVUS/VH-
derived compositional parameters. This statistical analysis
suggested that HD-NCP had the strongest correlation with
FI by IVUS/VH, whereas LD-NCP correlated with the
sum of NC  FF (Fig. 9).
iscussion
Our study has 3 significant aspects. First, to our knowledge,
this is the first study that implemented a relatively complex
design to include a detailed, multimodality approach to bor-
derline coronary arterial lesions using 3 morphological meth-
ods. Second, we have used a combination of a previously
validated, reproducible, 3-dimensional, segmental coregistra-
tion and a meticulous, slice-by-slice coregistration approach.
Fully quantitative, 3-dimensional plaque measurements by
CTA have not been validated against IVUS/VH in the past.
Figure 4. Scatterplots and Bland-Altman Plots for MLD and %DS Between
Scatterplots illustrate modest correlation between QCA and CTA for minimal lu
plots show small mean differences with relatively wide limits of agreement. Ab
Table 2. Segmental Correlation Between CTA and QCA Based on Anatomic
Mean Values
Correlation
Parameter
CTA
(Mean  SD)
QCA
(Mean  SD)
p Value for
t Test r Value p Va
MLD, mm 1.6 0.6 1.8 0.6 0.12 0.55 0.0
%DS 47.5 17.2 47.1 15.1 0.88 0.44 0.0CTA computed tomography angiography; MLDminimal lumen diameter; QCA quantitative coronaThird, based on our 2-tiered approach, we answered a clinically
relevant question about the accuracy of quantitative measure-
ments using a commercial platform on a segmental basis and a
research question about the accuracy of quantitative measure-
ments on a slice-by-slice basis.
The first important finding is that based on a 3-dimensional,
anatomical coregistration, there was significant correlation
between CTA- and IVUS/VH-derived plaque geometric and
compositional parameters (Fig. 2) (Table 3). Overall, mean
differences for these parameters were relatively small, whereas
the limits of agreement were wide, suggesting that such
quantitative CTA parameters might be safely used in popula-
tions, whereas the predictive accuracy on a per-patient basis is
limited. Limits of agreement between CTA and IVUS-VH for
quantitative measurements of stenosis on a slice-by-slice basis
were 50% to 54% and on a segmental basis were 66% to 97%.
For quantitative measurements of plaque volume and compo-
nd CTA
diameter (MLD) and percentage of diameter stenosis (%DS). Bland-Altman
ations as in Figure 1.
registration
Bland-Altman Analysis
Mean Difference
(Absolute)
Mean
Difference (%)
Limits of Agreement
(Absolute)
Limits of
Agreement (%)
0.15 10% 1.2 72%
0.03 2.8% 34 85%QCA a
menal Co
lue
01
01ry angiography; %DS percentage of diameter stenosis.
Figure
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204sition, limits of agreement on a segmental basis were 47% to
137% and on a slice-by-slice basis were 122% to 224%. These
wide limits of agreement indicate that using the present
acquisition and reconstruction techniques, and with the present
post-processing methods, such quantitative CTA-derived
measurements may not be precise enough for clinical use in
individual patients. By contrast, because correlation was mod-
erate to good between CTA- and IVUS/VH-derived param-
eters, and because mean differences were small, quantitative
CTAmeasurements may be used in population-based research
studies, with adequate sample size calculations.
Figure 5. Scatterplots and Bland-Altman Plots for Geometric Parameters, B
Scatterplots illustrate modest correlation between CTA and IVUS for MLD, %DS
mean differences with relatively wide limits of agreement. Abbreviations as in
Figure 6. Scatterplots and Bland-Altman Plots for Compositional Paramete
Scatterplots illustrate modest to good correlation between QCA and CTA for n
volume, and percentage of CP (%CP). Bland-Altman plots show small mean di
plaque; other abbreviations as in Figures 1 and 2.Calcium blooming in the region of maximal stenosis leads
to 21% underestimation of MLD by CTA, whereas %DS is
overestimated by 39%, as there is typically less calcium and,
therefore, less blooming in the area of the reference seg-
ment. Blooming of iodine in the lumen leads to 27%
overestimation of MLA by CTA, but as this is uniform
along the vessel, %AS was only underestimated by 5%. The
NCP volume had the strongest correlation (r 0.84), but it
was overestimated on CTA by 38%. The most important
limitation of CTA-based plaque quantification is the over-
estimation of calcified plaque volume and percentage, by
on Anatomical Coregistration
, and percentage of area stenosis (%AS). Bland-Altman plots show small
s 1, 2, and 4.
sed on Anatomical Coregistration
iﬁed plaque (NCP) volume, percentage of NCP (%NCP), calciﬁed plaque (CP)
es with relatively wide limits of agreement. CAP  calciﬁed atheroscleroticased
, MLArs, Ba
oncalc
fferenc
reviatio
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205104% and by 64%, respectively. It is important to point out
that our patients were selected with an intermediate steno-
sis; therefore, our data may lack the more extreme values on
either side of the population mean. This may contribute to
the relatively low correlation coefficients in our sample. We
also found that CT had increasing degrees of overestimation
of plaque volumes with true increases in plaque volume as
shown by IVUS, presumably because there are more bloom-
ing artifacts (data not shown).
The second important finding is that there was significant
correlation between CTA and IVUS/VH measurements of
lumen area, vessel area, PAV, NCP, and CAP in spatially
coregistered slices. Correlation coefficients for lumen area and
vessel area (0.77 and 0.72, respectively) indicate that CTA can
Figure 7. Scatterplots and Bland-Altman Plots for Geometric Parameters, B
Scatterplots illustrate good correlation for lumen area and vessel area and mo
Table 3. Segmental Correlation Between CTA and IVUS/VH Based on Anat
Mean Values
Correlation
Parameter
CTA
(Mean  SD)
IVUS/VH
(Mean  SD)
p Value for
t Test r Value p Va
MLD, mm 1.6 0.6 1.9 0.5 0.0001 0.59 0.
%DS 47.5 17.3 31.2 12.2 0.0001 0.43 0.
MLA, mm2 5.5 2.5 4.1 2.1 0.0001 0.65 0.
%AS 50.1 17.3 52.2 16.2 0.29 0.44 0.
CAP-V, mm3 77.6 71.6 20.7 21.8 0.0001 0.65 0.
CAP-% 29.8 17.3 14.0 8.7 0.0001 0.41 0.
NCP-V, mm3 155.7 86.5 113.0 73.2 0.0001 0.84 0.
NCP-% 70.2 17.3 86.0 8.7 0.0001 0.41 0.
%AS percentage of area stenosis; CAP-% percent calcified plaque; CAP-V calcified plaque vol
area; NCP-% percentage of noncalcified plaque; NCP-V noncalcified plaque volume; other abbshow small mean differences with relatively wide limits of agreement. Abbreviationstrack the slice-by-slice variation in lumen and vessel area
reasonably well. By contrast, lower correlation coefficients for
CAP area, NCP area, and PAV (0.43, 0.46, and 0.51,
respectively) indicate that CT’s ability for plaque quantification
is still somewhat limited (Fig. 3) (Table 4). Similar to the
segmental findings, CTA slightly overestimated lumen and
vessel area by 22% and 19%, respectively. Although NCP area
was only moderately overestimated on CTA (by 44%), CAP
area was overestimated by 88%. Importantly, mean PAV by
CTA and IVUS were 0.52 and 0.54, respectively (r  0.51;
p  0.001), satisfying the primary end point and confirming
the primary hypothesis of our study.
Finally, our statistical analysis suggested that HD-NCP
best correlates with FI and LD-NCP correlates with the
on Slice-by-Slice Coregistration of CTA and IVUS/VH
orrelation for percentage of atheroma volume (PAV). Bland-Altman plots
l Coregistration
Bland-Altman Analysis
Mean Difference
(Absolute)
Mean
Difference (%)
Limits of Agreement
(Absolute)
Limits of
Agreement (%)
0.3 21% 1.03 66%
15.8 39% 31.9 97%
1.5 27% 3.81 86%
2.7 5% 34.5 80%
55.4 104% 117 132%
15.7 64% 31.3 137%
40.8 38% 91.3 89%
15.7 22% 31.4 47%
US/VH intravascular ultrasoundwith radiofrequency backscatter analysis; MLAminimal lumen
ns as in Table 2.ased
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206sum of NC  FF on IVUS/VH. These statistical findings
are hypothesis-generating and need true imaging-based
validation by evaluating the spatial overlap between these
structures on CTA and IVUS/VH.
Our study adds significantly to the current literature on
the accuracy of CTA for coronary plaque quantification.
Leber et al. (11) previously showed in an initial feasibility
study using manual plaque delineation that correlation
was moderate between CTA and IVUS-derived plaque
quantification (r2  0.69) with relatively wide limits of
agreement (11), and that there was significant overlap in
Table 4. Slice-by-Slice Coregistration Between CTA and IVUS/VH
Mean Values
Correlat
Parameter
CTA
(Mean  SD)
IVUS/VH
(Mean  SD)
p Value for
t Test r Value p
Lumen area, mm2 8.5 3.4 6.7 2.6 0.0001 0.77 
Vessel area, mm2 18.2 6.4 14.9 4.7 0.0001 0.72 
PAV 0.52 0.13 0.54 0.13 0.0001 0.51 
CAP area, mm2 3.47 4.28 0.79 1.09 0.0001 0.43 
NCP area, mm2 6.08 2.40 4.34 2.69 0.0001 0.46 
CAP calcified plaque; NCP noncalcified plaque; PAV percentage of atheroma volume; other
Figure 8. Scatterplots and Bland-Altman Plots for Compositional Paramete
Scatterplots illustrate modest correlation for CP area and NCP area. Bland-Altm
in Figures 1, 2, and 6.CTA-derived tissue attenuation values between hy-
poechoic and hyperechoic NCP (49  22 HU and 91 
2 HU) (10). In 47 patients in a substudy of the
ROSPECT (Providing Regional Observations to Study
redictors of Events in the Coronary Tree) trial, Otsuka
t al. (16) found good correlation between CTA- and
VUS-derived plaque measurements with relatively wide
imits of agreement. A small study by Sun et al. (17)
ithout true anatomical or spatial coregistration found
odest correlation between CTA and grayscale IVUS
atasets for luminal cross-sectional area and for plaque
Bland-Altman Analysis
Mean Difference
(Absolute)
Mean
Difference (%)
Limits of Agreement
(Absolute)
Limits of
Agreement (%)
1.7 22% 4.2 54%
3.3 19% 8.7 50%
0.02 3.8% 0.25 50%
2.7 88% 7.7 224%
1.8 44% 5.2 122%
iations as in Tables 2 and 3.
sed on Slice-by-Slice Coregistration of CTA and IVUS/VH
ts show that both components are overestimated by CTA. Abbreviations asion
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207cross-sectional area. In another small study, Joshi et al.
(18) showed that CTA and IVUS were much better
correlated than QCA and CTA. Our study expanded on
these findings and showed better correlation between
QCA- and CTA-derived MLD and %DS, probably
given the more standardized, validated approach we used
for CTA analysis (16,18).
Pundziute et al. (19) showed that compared with calcified
plaques, NCPs contained more FI and FF tissue on IVUS/
VH, whereas mixed and calcified plaques contained more
dense calcium, compared with NCPs. Furthermore, IVUS/
VH-based thin cap fibroatheromas were most frequent in
mixed plaques (32%) (19,20). Our study expands signifi-
cantly on these findings, because we also precisely quantified
plaque components on CTA.
An important clinical implication of the present study is
that it confirmed that when quantitative plaque analysis of
CTA datasets is performed using a commercially available
Figure 9. Correlation for HD-NCP and LD-NCP Against IVUS/VH Parameters
Scatterplots illustrate modest correlation between high-density (HD) NCP and
fatty (FF) tissue plus necrotic core (NC). Bland-Altman plots show that these copost-processing workstation with a standardized approach son a segmental basis, CTA-derived MLD, %DS, MLA,
%AS, and NCP correlate significantly with IVUS/VH
measurements in a population, but not on a per-patient
basis. Given this degree of validation of CTA, quantitative
plaque parameters may be incorporated in carefully designed
clinical studies for the assessment of coronary atherosclero-
sis (14).
Study limitations. Although this was a complex, prospective
tudy with a pre-specified primary end point, it has several
imitations. First, CTA studies at baseline were performed
n a 64-slice scanner system; today, there are newer-
eneration scanners available. The current phase of our
tudy is performed on a 320-multidetector-row system.
econd, our study lesions were limited to 40% to 70%
tenoses; the current, ongoing second phase of the study is
nrolling patients with 71% to 99% stenoses. The lack of
ore extreme values around the population mean may have
ontributed to the observed lower correlation coefficients for
s (FI) tissue and poor correlation between low-density (LD) NCP and ﬁbro-
ents are overestimated by CTA. Abbreviations as in Figures 1 and 6.ﬁbrouome of the measurements. Finally, 10 of the 60 prospectively
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208enrolled patients were excluded from the final analysis because
of technical problems; this may have introduced some bias.
Conclusions
To our knowledge, this was the first prospective study to
implement a 3-dimensional, quantitative analysis of coregis-
tered CTA and IVUS/VH datasets for the assessment of
nonobstructive coronary arterial plaques. We found significant
correlation between CTA and IVUS/VH with small mean
differences, suggesting that quantitative CTA measurements
may be used in population-based approaches. However, the
relatively wide limits of agreement suggest that CTA quanti-
fication should only supplement, and not replace, the clinically
used, more descriptive interpretations. Coronary CTA is a
promising, emerging tool for the quantification of coronary
arterial atherosclerotic plaques.
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